BCR-ABL-Negative
Showing 1 - 25 of >10,000
Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online
Recruiting
- Myeloproliferative Neoplasm
- +2 more
- Online Mindfulness Meditation
- Internet-Based Webinars
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 9, 2022
Myeloproliferative Tumor Trial in Toronto (Azacitidine, Venetoclax)
Not yet recruiting
- Myeloproliferative Neoplasm
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 12, 2022
Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)
Recruiting
- Primary Myelofibrosis
- +9 more
- Observational
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 11, 2022
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)
Recruiting
- Acute Myeloid Leukemia
- +6 more
- Hyperbaric oxygen
-
Rochester, New YorkWilmot Cancer Institute, University of Rochester
May 16, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Myelodysplastic Syndrome, Myeloproliferative Tumors, Chronic Myelomonocytic Leukemia Trial in United States (other, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Geriatric assessment (GA) pre-transplant
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Aug 24, 2022
Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)
Terminated
- Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
-
Badalona, Barcelona, Spain
- +11 more
Jul 26, 2022
Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)
Recruiting
- Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Acute Lymphoblastic Leukemia Trial in Spain (Pediatric-type of chemo, allogeneic HSCT)
Recruiting
- Acute Lymphoblastic Leukemia
- Pediatric-type of chemotherapy
- allogeneic HSCT
-
Badalona, Barcelona, Spain
- +107 more
Feb 17, 2022
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Neutrophilic Leukemia Trial in United States (Laboratory Biomarker
Completed
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- Chronic Neutrophilic Leukemia
- Laboratory Biomarker Analysis
- +3 more
-
Palo Alto, California
- +6 more
Oct 22, 2020
B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- ABL001
- +2 more
-
Chicago, Illinois
- +5 more
Dec 27, 2021
Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia
- +3 more
- Dasatinib
- Decitabine and Cedazuridine
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic
Active, not recruiting
- Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Dexamethasone
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 2, 2022
Outcomes in Chronic Myeloid Leukaemia
Completed
- Chronic Myeloid Leukaemia
-
York, United KingdomHaematological Malignancy Research Network
Jun 7, 2023
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
- Dasatinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 24, 2022
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)
Completed
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Angers, France
- +9 more
Aug 17, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Decitabine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
According to Molecular Identification at Diagnosis
Not yet recruiting
- Chronic Myeloid Leukemia
- Next Generation Sequencing (DNA and RNA)
- (no location specified)
Oct 28, 2022
Asciminib RMP Study
Not yet recruiting
- Chronic Myeloid Leukemia
- Asciminib
- (no location specified)
Jul 5, 2023
Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei
Not yet recruiting
- Chronic Myeloid Leukemia, BCR/ABL-Positive
-
Taipei, TaiwanNational Taiwan University Hospital
Jul 24, 2022